# pH‐Dependent Microenvironmental Ionic Signaling in Pancreatic Ductal Adenocarcinoma

## TL;DR

This paper explores how pH changes in the pancreas influence pancreatic cancer development and suggest targeting pH-regulating proteins as a potential treatment.

## Contribution

The paper highlights the novel role of pH-regulatory transport proteins in shaping the pancreatic cancer microenvironment and their potential as therapeutic targets.

## Key findings

- pH-regulatory transport proteins act as signaling hubs influencing cancer cell behavior and immune evasion.
- Inhibiting pH-regulatory proteins in mouse models impacts tumor immune defense and cancer-immune cell communication.
- These proteins, essential for normal pancreas function, are co-opted to support cancer progression.

## Abstract

Pancreatic ductal adenocarcinoma (PDAC) develops within a uniquely dynamic pH landscape shaped by substantial acid–base fluxes produced by the exocrine pancreas. Secretion of alkaline pancreatic juice, normally linked to digestion, produces intermittent acidifications of the pancreatic interstitium, which challenges epithelial and stromal cells. It was postulated that these unique pancreatic pH dynamics can facilitate PDAC initiation and progression through selection of a more aggressive phenotype emerging with PDAC driver mutations.

Here, we summarize evidence that pH‐regulatory transport proteins have an important role in shaping the PDAC microenvironment.

pH‐regulatory transport proteins generate and sense their microenvironment and act as signaling hubs to regulate proliferation, migration, and metabolism, and immune evasion. In this way, transport proteins that are crucial for the normal physiology of the exocrine pancreas are misused and become coerced into playing a pro‐cancer role in pancreatic tumor cells, pancreatic stellate cells, or infiltrating immune cells. Experiments with PDAC mouse models revealed a therapeutic potential of targeting pH dynamics, notably by inhibition or genetic ablation of pH‐regulatory proteins. It is a consistent finding that these maneuvers have a marked impact on the tumor immune defense and the communication between cancer and immune cells.

Collectively, we present a case for considering pH‐regulating proteins as a therapeutic avenue.